Latest
-
Just how much of a threat is rising inflation?
Briefings Investors are getting spooked by the prospect of rising prices. But how much of a threat is that really? Simon Wilson reports
Briefings -
What’s driving the oil price volatility, and where could it go next?
Briefings The oil price has whipsawed in volatile trading, after Opec delayed a key production meeting. Saloni Sardana looks at what's going on, and where the oil price could go from here.
Briefings -
Artists demand a fair share of the music industry pie
Briefings Technology once threatened to destroy the music industry, now it's helping it thrive. But while investors are making a packet, artists says they are not getting their fair share.
Briefings -
Why are childcare costs in Britain so exorbitant?
Briefings Working parents who have to pay for care for their children will know that it costs a lot of money. Indeed, it costs more here than anywhere else in the world.
Briefings -
Why our rickety internet infrastructure needs an upgrade
Briefings The internet is an increasingly essential part of international infrastructure. Recent events have shown that it is also vulnerable to collapse.
Briefings -
The G7’s global corporation tax: bringing Big Tech to heel
Briefings The G7 group of nations has agreed to potentially historic changes in the way multinational companies are taxed. Who wins and who loses?
Briefings -
The government says it wants to build more houses – but will it?
Briefings As PM, Boris Johnson is pushing through reforms that should make it easier to build more houses. As a local MP, he opposes such plans. Which of these tendencies will win out?
Briefings -
Britain's rail industry is being revamped. Here is all you need to know about it
Briefings After more than a year of waiting, the UK's government's white paper on the future of the rail industry is finally out. Simon Wilson explains everything you need to know about it.
Briefings -
Why Joe Biden’s Big Pharma patent grab is a terrible idea
Briefings The US president has proposed waiving patents on Covid-19 vaccines in a bid to boost global supply. But it won’t work on its own terms and holds dangers for the future.
Briefings
